Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Anika completes phase III trial on Orthovisc

Sep. 4, 1997

New MMP and TNF inhibitor from Kanebo

Sep. 2, 1997

Hyalgan introduced in U.S. for osteoarthritis of the knee

Sep. 1, 1997

Pharos receives patent for novel method of controlling and treating inflammation

Aug. 29, 1997

Stromelysin inhibitors: New approach to treating arthritis?

Aug. 29, 1997

Familial Mediterranean fever gene discovered

Aug. 28, 1997

MMP inhibitors effective in rat model of arthritis

Aug. 26, 1997

Antiinflammatory selectin-binding peptides from Affymax

Aug. 25, 1997

Indomethacin prodrug with potent antiinflammatory effects, low ulcerogenicity

Aug. 25, 1997

New COX-2 inhibitor series reported by Searle

Aug. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...